20:53:25 EDT Fri 03 May 2024
Enter Symbol
or Name
USA
CA



Xebra Brands Ltd (2)
Symbol XBRA
Shares Issued 71,375,222
Close 2024-04-15 C$ 0.10
Market Cap C$ 7,137,522
Recent Sedar Documents

Xebra receives second CBD product approval by COFEPRIS

2024-04-16 15:23 ET - News Release

Mr. Rodrigo Gallardo reports

XEBRA BRANDS RECEIVES SECOND CBD PRODUCT APPROVAL BY COFEPRIS

Xebra Brands Ltd. has received approval from the Federal Commission for the Protection against Sanitary Risk (COFEPRIS) for its second CBD product authorization to be sold in Mexico. This latest approval marks another milestone for Xebra Brands and highlights the company's commitment to providing high-quality CBD products to consumers in Mexico.

Building on the success of its first product approval in Mexico, Xebra Brands has obtained authorization for the importation, launch and sale of an additional 250-milligram tincture, expanding its product offerings to meet the growing demand for premium CBD options in the region. Similar to its previously approved tangerine flavour CBD tincture, this new product reflects Xebra's dedication to innovation, quality and compliance within the CBD industry.

"We are thrilled to receive approval from COFEPRIS for an additional CBD product to be sold in Mexico," said Rodrigo Gallardo, interim chief executive officer of Xebra Brands. "This demonstrates not only the responsiveness of regulatory authorities but also the trust they place in our commitment to providing safe, legal and effective CBD products to consumers over what is currently available. We are excited to continue our mission of expanding access to premium CBD products in Mexico."

Xebra Brands' 250 mg tincture is formulated with the same dedication to quality and purity as its previous offerings. Crafted with premium CBD extract, each batch of tincture undergoes thorough testing by third party laboratories to ensure potency and consistency. This commitment to quality ensures that consumers in Mexico have access to trusted and reliable CBD products.

With the approval of its second product by COFEPRIS, Xebra Brands reaffirms its position as a leader in the Mexican CBD industry. The company remains dedicated to meeting the evolving needs of consumers and providing natural wellness solutions that promote stress relief, relaxation and overall well-being.

Xebra Brands looks forward to bringing its tinctures to market and growing its retail consumer base within the population of approximately 130 million people in Mexico.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.